Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.